drugset / Trial / NCT01417390

Study of Neoadjuvant Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma

NCT01417390 ↗

Phase 2 Unknown 80 enrolled First People's Hospital of Foshan
RandomizedSingle-groupSingle-blindTreatment

Summary

The purpose of this study is to compare induction chemotherapy (gemcitabine+cisplatin) plus concurrent chemoradiotherapy with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma (NPC), in order to confirm the value of induction chemotherapy using gemcitabine and cisplatin in NPC patients.

Timeline

Start
2011-11
Primary completion
2014-12
Completion
2015-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 20 mg/m2 —
Subject Cisplatin Other / unclassified 40 mg/m2 —
Subject Gemcitabine Small molecule 1000 mg/m2 —